SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Revolution Medicines, Inc. RVMD NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Revolution Medicines, Inc. (RVMD) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 AGIO, AKRO, BCEL, BDTX, BPMC, CCCC 等.

RVMD 的市值为 $29.13B, 而同行平均市值为 $2.65B. RVMD 显著大于其平均同行.

同行与相似公司 — RVMD

Agios Pharmaceuticals, Inc.

$33.30 +0.45% $1.95B

Akero Therapeutics, Inc.

$54.65 0.00% $4.5B

$0.09 -1.32% $3.57M

Black Diamond Therapeutics, Inc.

$2.66 -2.21% $152.39M

Blueprint Medicines Corporation

$129.46 +0.14% $8.36B

C4 Therapeutics, Inc.

$2.76 +0.91% $228.6M

Homology Medicines, Inc.

$0.93 +0.77% $3.02M

Monte Rosa Therapeutics, Inc.

$17.50 -0.28% $1.14B

Kymera Therapeutics, Inc.

$89.87 +1.51% $7.34B

Nurix Therapeutics, Inc.

$16.30 +2.45% $1.41B

Passage Bio, Inc.

$10.86 +0.46% $34.84M

Protagonist Therapeutics, Inc.

$104.72 +7.33% $6.68B

其他人也在看

Blueprint Medicines Corporation

Kymera Therapeutics, Inc.

Protagonist Therapeutics, Inc.

Akero Therapeutics, Inc.

Stoke Therapeutics, Inc.

Agios Pharmaceuticals, Inc.

Nurix Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言